A detailed history of Jefferies Financial Group Inc. transactions in Neogenomics Inc stock. As of the latest transaction made, Jefferies Financial Group Inc. holds 25,001 shares of NEO stock, worth $349,513. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25,001
Holding current value
$349,513
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$13.4 - $17.73 $335,013 - $443,267
25,001 New
25,001 $368,000
Q4 2023

Feb 13, 2024

BUY
$11.67 - $20.73 $179,986 - $319,718
15,423 New
15,423 $249,000

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.76B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Jefferies Financial Group Inc. Portfolio

Follow Jefferies Financial Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Financial Group Inc. with notifications on news.